25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

000153 (Anhui Fengyuan Pharmaceutical Co Ltd) Stock Analysis
Buy, Hold or Sell?

Let's analyze Anhui Fengyuan Pharmaceutical Co Ltd together

I guess you are interested in Anhui Fengyuan Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Anhui Fengyuan Pharmaceutical Co Ltd’s Financial Insights
  • 📈 Technical Analysis (TA) – Anhui Fengyuan Pharmaceutical Co Ltd’s Price Targets

I'm going to help you getting a better view of Anhui Fengyuan Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Anhui Fengyuan Pharmaceutical Co Ltd

I send you an email if I find something interesting about Anhui Fengyuan Pharmaceutical Co Ltd.

1. Quick Overview

1.1. Quick analysis of Anhui Fengyuan Pharmaceutical Co Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Anhui Fengyuan Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.02
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥4.35
Expected worth in 1 year
¥4.63
How sure are you?
95.0%

+ What do you gain per year?

Total Gains per Share
¥0.45
Return On Investment
7.2%

For what price can you sell your share?

Current Price per Share
¥6.30
Expected price per share
¥5.93 - ¥6.97
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Anhui Fengyuan Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)
¥6.30
Intrinsic Value Per Share
¥-0.51 - ¥7.48
Total Value Per Share
¥3.84 - ¥11.83

2.2. Growth of Anhui Fengyuan Pharmaceutical Co Ltd (5 min.)




Is Anhui Fengyuan Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$278.6m$251.4m$20.3m7.5%

How much money is Anhui Fengyuan Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$5.6m$5.8m-$215.9k-3.8%
Net Profit Margin3.8%3.9%--

How much money comes from the company's main activities?

2.3. Financial Health of Anhui Fengyuan Pharmaceutical Co Ltd (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Anhui Fengyuan Pharmaceutical Co Ltd?

Welcome investor! Anhui Fengyuan Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Anhui Fengyuan Pharmaceutical Co Ltd.

First you should know what it really means to hold a share of Anhui Fengyuan Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Anhui Fengyuan Pharmaceutical Co Ltd is ¥6.3. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Anhui Fengyuan Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Anhui Fengyuan Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥4.35. Based on the TTM, the Book Value Change Per Share is ¥0.07 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.08 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.04 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Anhui Fengyuan Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.010.2%0.010.2%0.010.2%0.010.2%0.010.1%
Usd Book Value Change Per Share0.010.2%0.010.2%0.010.2%0.010.2%0.010.1%
Usd Dividend Per Share0.000.0%0.010.1%0.000.1%0.000.1%0.010.1%
Usd Total Gains Per Share0.020.2%0.020.2%0.020.2%0.010.2%0.010.2%
Usd Price Per Share0.84-0.99-1.49-1.22-1.28-
Price to Earnings Ratio15.10-27.75-32.74-39.62-547.82-
Price-to-Total Gains Ratio54.35-68.12-143.43-113.26--8.12-
Price to Book Ratio1.41-1.70-2.77-2.54-3.14-
Price-to-Total Gains Ratio54.35-68.12-143.43-113.26--8.12-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.86814
Number of shares1151
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.00
Usd Book Value Change Per Share0.010.01
Usd Total Gains Per Share0.020.01
Gains per Quarter (1151 shares)17.9816.65
Gains per Year (1151 shares)71.9066.58
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1274562194857
254901343896124
38113520656143191
410817927875191258
513522435094239325
6162269422113287392
7189314494131335459
8216359566150382526
9243404638169430593
10270449710188478660

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%87.00.04.095.6%
Book Value Change Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%36.04.00.090.0%81.010.00.089.0%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%82.00.09.090.1%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%38.02.00.095.0%89.02.00.097.8%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Anhui Fengyuan Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0980.071+38%0.080+23%0.075+30%0.048+106%
Book Value Per Share--4.3504.243+3%3.926+11%3.560+22%3.085+41%
Current Ratio--0.9330.940-1%0.928+1%0.902+3%0.602+55%
Debt To Asset Ratio--0.5660.573-1%0.581-3%0.592-4%0.566+0%
Debt To Equity Ratio--1.3231.362-3%1.416-7%1.481-11%1.342-1%
Dividend Per Share--0.0150.043-65%0.032-54%0.030-50%0.039-62%
Enterprise Value--202583075.930690555968.338-71%2494415155.295-92%1736165793.578-88%2383785523.998-92%
Eps--0.1010.088+15%0.092+11%0.074+37%0.052+94%
Ev To Ebitda Ratio--infnannan%infnan%nannan%nannan%
Ev To Sales Ratio--0.0530.164-68%0.577-91%0.460-88%0.990-95%
Free Cash Flow Per Share--0.0120.011+13%0.184-93%0.058-79%0.031-61%
Free Cash Flow To Equity Per Share--0.0120.011+13%-0.080+763%-0.005+145%0.014-17%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--7.484--------
Intrinsic Value_10Y_min---0.510--------
Intrinsic Value_1Y_max--0.417--------
Intrinsic Value_1Y_min--0.095--------
Intrinsic Value_3Y_max--1.507--------
Intrinsic Value_3Y_min--0.161--------
Intrinsic Value_5Y_max--2.903--------
Intrinsic Value_5Y_min--0.089--------
Market Cap2928076300.800+3%2844800738.6403337527663.960-15%5035838082.710-44%4129142403.960-31%4306175119.213-34%
Net Profit Margin--0.0490.038+30%0.039+25%0.035+40%0.029+68%
Operating Margin----0%0.070-100%0.044-100%0.028-100%
Operating Ratio--1.7491.717+2%1.672+5%1.653+6%1.300+35%
Pb Ratio1.448+3%1.4071.698-17%2.770-49%2.538-45%3.143-55%
Pe Ratio15.547+3%15.10327.748-46%32.743-54%39.621-62%547.824-97%
Price Per Share6.300+3%6.1207.180-15%10.835-44%8.884-31%9.265-34%
Price To Free Cash Flow Ratio130.781+3%127.04414.566+772%-41.965+133%-36.185+128%-59.368+147%
Price To Total Gains Ratio55.947+3%54.34868.116-20%143.432-62%113.258-52%-8.120+115%
Quick Ratio--0.4730.453+4%0.434+9%0.422+12%0.457+4%
Return On Assets--0.0100.009+15%0.010+3%0.008+21%0.007+49%
Return On Equity--0.0240.021+12%0.0240%0.021+14%0.016+46%
Total Gains Per Share--0.1130.113-1%0.112+1%0.105+7%0.087+30%
Usd Book Value--278660125.099271761475.369+3%251455943.629+11%228033351.370+22%197570099.602+41%
Usd Book Value Change Per Share--0.0130.010+38%0.011+23%0.010+30%0.007+106%
Usd Book Value Per Share--0.5990.585+3%0.541+11%0.491+22%0.425+41%
Usd Dividend Per Share--0.0020.006-65%0.004-54%0.004-50%0.005-62%
Usd Enterprise Value--27915947.86395158612.437-71%343730408.400-92%239243646.355-88%328485645.207-92%
Usd Eps--0.0140.012+15%0.013+11%0.010+37%0.007+94%
Usd Free Cash Flow--771412.707684522.737+13%11814646.823-93%3720489.135-79%1989377.144-61%
Usd Free Cash Flow Per Share--0.0020.001+13%0.025-93%0.008-79%0.004-61%
Usd Free Cash Flow To Equity Per Share--0.0020.001+13%-0.011+763%-0.001+145%0.002-17%
Usd Market Cap403488914.250+3%392013541.785459911312.094-15%693938487.797-44%568995823.266-31%593390931.428-34%
Usd Price Per Share0.868+3%0.8430.989-15%1.493-44%1.224-31%1.277-34%
Usd Profit--6489051.3675654082.424+15%5870026.738+11%4720416.740+37%3341420.150+94%
Usd Revenue--131398690.494148575636.956-12%150292025.975-13%132399775.799-1%107537511.655+22%
Usd Total Gains Per Share--0.0160.016-1%0.015+1%0.014+7%0.012+30%
 EOD+4 -4MRQTTM+22 -15YOY+21 -175Y+22 -1610Y+21 -17

3.3 Fundamental Score

Let's check the fundamental score of Anhui Fengyuan Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1515.547
Price to Book Ratio (EOD)Between0-11.448
Net Profit Margin (MRQ)Greater than00.049
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.473
Current Ratio (MRQ)Greater than10.933
Debt to Asset Ratio (MRQ)Less than10.566
Debt to Equity Ratio (MRQ)Less than11.323
Return on Equity (MRQ)Greater than0.150.024
Return on Assets (MRQ)Greater than0.050.010
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of Anhui Fengyuan Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.354
Ma 20Greater thanMa 506.120
Ma 50Greater thanMa 1006.072
Ma 100Greater thanMa 2006.251
OpenGreater thanClose6.270
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Anhui Fengyuan Pharmaceutical Co Ltd

Anhui Fengyuan Pharmaceutical Co., Ltd. researches and develops, produces, and sells biopharmaceuticals, chemical pharmaceuticals, Chinese patent medicines, Chinese herbal decoction pieces, and APIs primarily in China. It offers products in various categories, which includes gynecology, respiratory system, hormonal, antipyretic analgesic, mental class, antiviral class, antibiotic class, oral anesthetic, masks class, urinary, water electrolyte balance, digestive system, cardiovascular class, Yinpian class, and nutrition and metabolism, as well as provides raw material drugs. The company also exports its products to Africa, Southeast Asia, Central Asia, Europe, and internationally. Anhui Fengyuan Pharmaceutical Co., Ltd. was founded in 1997 and is based in Hefei, China.

Fundamental data was last updated by Penke on 2025-03-22 20:29:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Anhui Fengyuan Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Anhui Fengyuan Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 4.9% means that ¥0.05 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Anhui Fengyuan Pharmaceutical Co Ltd:

  • The MRQ is 4.9%. The company is making a profit. +1
  • The TTM is 3.8%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ4.9%TTM3.8%+1.1%
TTM3.8%YOY3.9%-0.1%
TTM3.8%5Y3.5%+0.3%
5Y3.5%10Y2.9%+0.6%
4.3.1.2. Return on Assets

Shows how efficient Anhui Fengyuan Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Anhui Fengyuan Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.0% Return on Assets means that Anhui Fengyuan Pharmaceutical Co Ltd generated ¥0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Anhui Fengyuan Pharmaceutical Co Ltd:

  • The MRQ is 1.0%. Using its assets, the company is less efficient in making profit.
  • The TTM is 0.9%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.0%TTM0.9%+0.1%
TTM0.9%YOY1.0%-0.1%
TTM0.9%5Y0.8%+0.0%
5Y0.8%10Y0.7%+0.2%
4.3.1.3. Return on Equity

Shows how efficient Anhui Fengyuan Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Anhui Fengyuan Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 2.4% Return on Equity means Anhui Fengyuan Pharmaceutical Co Ltd generated ¥0.02 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Anhui Fengyuan Pharmaceutical Co Ltd:

  • The MRQ is 2.4%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.1%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.4%TTM2.1%+0.3%
TTM2.1%YOY2.4%-0.3%
TTM2.1%5Y2.1%+0.0%
5Y2.1%10Y1.6%+0.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Anhui Fengyuan Pharmaceutical Co Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Anhui Fengyuan Pharmaceutical Co Ltd is operating .

  • Measures how much profit Anhui Fengyuan Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Anhui Fengyuan Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Anhui Fengyuan Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY7.0%-7.0%
TTM-5Y4.4%-4.4%
5Y4.4%10Y2.8%+1.5%
4.3.2.2. Operating Ratio

Measures how efficient Anhui Fengyuan Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.75 means that the operating costs are ¥1.75 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Anhui Fengyuan Pharmaceutical Co Ltd:

  • The MRQ is 1.749. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.717. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.749TTM1.717+0.032
TTM1.717YOY1.672+0.045
TTM1.7175Y1.653+0.064
5Y1.65310Y1.300+0.352
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Anhui Fengyuan Pharmaceutical Co Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Anhui Fengyuan Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 0.93 means the company has ¥0.93 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Anhui Fengyuan Pharmaceutical Co Ltd:

  • The MRQ is 0.933. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.940. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.933TTM0.940-0.007
TTM0.940YOY0.928+0.012
TTM0.9405Y0.902+0.038
5Y0.90210Y0.602+0.300
4.4.3.2. Quick Ratio

Measures if Anhui Fengyuan Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Anhui Fengyuan Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.47 means the company can pay off ¥0.47 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Anhui Fengyuan Pharmaceutical Co Ltd:

  • The MRQ is 0.473. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.453. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.473TTM0.453+0.020
TTM0.453YOY0.434+0.019
TTM0.4535Y0.422+0.031
5Y0.42210Y0.457-0.035
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Anhui Fengyuan Pharmaceutical Co Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Anhui Fengyuan Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Anhui Fengyuan Pharmaceutical Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.57 means that Anhui Fengyuan Pharmaceutical Co Ltd assets are financed with 56.6% credit (debt) and the remaining percentage (100% - 56.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Anhui Fengyuan Pharmaceutical Co Ltd:

  • The MRQ is 0.566. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.573. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.566TTM0.573-0.006
TTM0.573YOY0.581-0.009
TTM0.5735Y0.592-0.020
5Y0.59210Y0.566+0.026
4.5.4.2. Debt to Equity Ratio

Measures if Anhui Fengyuan Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Anhui Fengyuan Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 132.3% means that company has ¥1.32 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Anhui Fengyuan Pharmaceutical Co Ltd:

  • The MRQ is 1.323. The company is able to pay all its debts with equity. +1
  • The TTM is 1.362. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.323TTM1.362-0.039
TTM1.362YOY1.416-0.054
TTM1.3625Y1.481-0.119
5Y1.48110Y1.342+0.139
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Anhui Fengyuan Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Anhui Fengyuan Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 15.10 means the investor is paying ¥15.10 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Anhui Fengyuan Pharmaceutical Co Ltd:

  • The EOD is 15.547. Based on the earnings, the company is fair priced.
  • The MRQ is 15.103. Based on the earnings, the company is fair priced.
  • The TTM is 27.748. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD15.547MRQ15.103+0.444
MRQ15.103TTM27.748-12.645
TTM27.748YOY32.743-4.995
TTM27.7485Y39.621-11.873
5Y39.62110Y547.824-508.204
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Anhui Fengyuan Pharmaceutical Co Ltd:

  • The EOD is 130.781. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 127.044. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 14.566. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD130.781MRQ127.044+3.737
MRQ127.044TTM14.566+112.478
TTM14.566YOY-41.965+56.531
TTM14.5665Y-36.185+50.751
5Y-36.18510Y-59.368+23.183
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Anhui Fengyuan Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Anhui Fengyuan Pharmaceutical Co Ltd:

  • The EOD is 1.448. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.407. Based on the equity, the company is underpriced. +1
  • The TTM is 1.698. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.448MRQ1.407+0.041
MRQ1.407TTM1.698-0.292
TTM1.698YOY2.770-1.072
TTM1.6985Y2.538-0.840
5Y2.53810Y3.143-0.605
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets4,664,425
Total Liabilities2,642,218
Total Stockholder Equity1,996,909
 As reported
Total Liabilities 2,642,218
Total Stockholder Equity+ 1,996,909
Total Assets = 4,664,425

Assets

Total Assets4,664,425
Total Current Assets2,015,072
Long-term Assets2,649,353
Total Current Assets
Cash And Cash Equivalents 241,416
Net Receivables 1,022,282
Inventory 579,235
Other Current Assets 23,348
Total Current Assets  (as reported)2,015,072
Total Current Assets  (calculated)1,866,281
+/- 148,790
Long-term Assets
Property Plant Equipment 1,581,741
Goodwill 7,920
Intangible Assets 288,665
Long-term Assets Other 46,159
Long-term Assets  (as reported)2,649,353
Long-term Assets  (calculated)1,924,485
+/- 724,869

Liabilities & Shareholders' Equity

Total Current Liabilities2,159,403
Long-term Liabilities482,814
Total Stockholder Equity1,996,909
Total Current Liabilities
Short Long Term Debt 383,143
Accounts payable 776,153
Other Current Liabilities 6,822
Total Current Liabilities  (as reported)2,159,403
Total Current Liabilities  (calculated)1,166,118
+/- 993,285
Long-term Liabilities
Long term Debt 210,905
Capital Lease Obligations Min Short Term Debt15,119
Long-term Liabilities  (as reported)482,814
Long-term Liabilities  (calculated)226,024
+/- 256,790
Total Stockholder Equity
Retained Earnings 986,234
Total Stockholder Equity (as reported)1,996,909
Total Stockholder Equity (calculated)986,234
+/- 1,010,675
Other
Capital Stock464,837
Common Stock Shares Outstanding 464,837
Net Debt 352,632
Net Invested Capital 2,590,957
Net Working Capital -144,332
Property Plant and Equipment Gross 1,581,741



6.2. Balance Sheets Structured

Currency in CNY. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-06-302000-12-31
> Total Assets 
634,786
739,840
709,482
700,973
711,480
698,909
684,422
701,556
716,373
716,915
736,925
777,108
786,534
852,316
895,922
925,216
1,058,782
1,086,470
1,092,666
1,107,896
1,100,631
1,136,000
1,065,594
1,062,590
1,152,176
1,111,729
1,088,619
1,168,754
1,140,790
1,166,300
1,165,556
1,211,521
1,228,740
1,208,500
1,205,474
1,175,814
1,147,182
1,274,567
1,275,831
1,299,820
1,326,300
1,342,194
1,318,230
1,348,051
1,434,108
1,450,875
1,450,487
1,801,494
1,822,625
1,844,132
1,981,023
2,072,341
2,104,185
2,156,990
2,237,533
2,250,722
2,229,514
2,290,039
2,305,281
2,445,649
2,446,540
2,476,102
2,490,374
2,577,724
2,672,176
2,745,166
2,767,715
2,816,793
2,923,169
2,968,289
3,007,998
3,094,692
3,211,654
3,332,456
3,559,615
3,632,937
3,506,551
3,517,291
3,636,208
3,784,012
3,799,525
3,767,474
3,816,330
4,024,285
3,900,361
4,069,911
4,469,240
4,407,882
4,432,585
4,155,141
4,391,320
4,703,099
4,717,620
4,664,425
4,664,4254,717,6204,703,0994,391,3204,155,1414,432,5854,407,8824,469,2404,069,9113,900,3614,024,2853,816,3303,767,4743,799,5253,784,0123,636,2083,517,2913,506,5513,632,9373,559,6153,332,4563,211,6543,094,6923,007,9982,968,2892,923,1692,816,7932,767,7152,745,1662,672,1762,577,7242,490,3742,476,1022,446,5402,445,6492,305,2812,290,0392,229,5142,250,7222,237,5332,156,9902,104,1852,072,3411,981,0231,844,1321,822,6251,801,4941,450,4871,450,8751,434,1081,348,0511,318,2301,342,1941,326,3001,299,8201,275,8311,274,5671,147,1821,175,8141,205,4741,208,5001,228,7401,211,5211,165,5561,166,3001,140,7901,168,7541,088,6191,111,7291,152,1761,062,5901,065,5941,136,0001,100,6311,107,8961,092,6661,086,4701,058,782925,216895,922852,316786,534777,108736,925716,915716,373701,556684,422698,909711,480700,973709,482739,840634,786
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,664,367
1,648,271
1,588,156
1,762,493
1,828,979
1,924,597
1,739,207
1,786,505
1,667,906
1,658,442
1,738,288
1,780,002
1,792,176
1,705,883
1,694,771
1,868,813
1,726,015
1,873,077
2,077,408
2,005,573
1,988,283
1,724,164
1,902,911
2,124,341
2,124,161
2,015,072
2,015,0722,124,1612,124,3411,902,9111,724,1641,988,2832,005,5732,077,4081,873,0771,726,0151,868,8131,694,7711,705,8831,792,1761,780,0021,738,2881,658,4421,667,9061,786,5051,739,2071,924,5971,828,9791,762,4931,588,1561,648,2711,664,36700000000000000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
285,840
295,799
303,590
217,544
279,202
344,604
350,726
331,597
241,402
245,602
275,336
287,827
300,337
258,092
251,305
255,104
283,229
433,704
353,138
202,391
241,785
207,379
319,905
335,906
252,205
241,416
241,416252,205335,906319,905207,379241,785202,391353,138433,704283,229255,104251,305258,092300,337287,827275,336245,602241,402331,597350,726344,604279,202217,544303,590295,799285,84000000000000000000000000000000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
193,569
192,837
195,437
9,873
1,897
6,916
6,948
6,989
7,031
7,070
0
0
0
2,000
0
0
0
0
0
0
0
0
0
0000000002,0000007,0707,0316,9896,9486,9161,8979,873195,437192,837193,56900000000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
55,956
60,837
85,966
107,149
98,009
113,266
114,108
117,523
135,779
141,567
156,799
187,421
172,632
206,496
214,787
233,158
247,931
285,781
222,673
240,393
248,072
262,304
354,473
353,008
380,510
343,643
310,700
342,447
321,162
339,444
303,107
330,682
317,170
327,368
319,905
290,273
286,250
377,368
273,634
293,793
305,902
318,259
293,111
346,698
372,007
376,689
318,111
349,275
367,564
385,614
359,333
416,888
438,577
482,485
490,867
490,617
469,604
495,372
463,953
506,826
542,950
550,127
644,939
709,856
756,112
755,889
751,927
768,585
837,946
775,374
722,827
688,805
674,160
683,814
726,903
809,232
811,882
805,887
811,112
829,872
862,754
818,963
736,752
883,119
791,799
781,056
804,502
972,531
1,000,838
849,909
791,523
1,025,692
1,112,800
1,022,282
1,022,2821,112,8001,025,692791,523849,9091,000,838972,531804,502781,056791,799883,119736,752818,963862,754829,872811,112805,887811,882809,232726,903683,814674,160688,805722,827775,374837,946768,585751,927755,889756,112709,856644,939550,127542,950506,826463,953495,372469,604490,617490,867482,485438,577416,888359,333385,614367,564349,275318,111376,689372,007346,698293,111318,259305,902293,793273,634377,368286,250290,273319,905327,368317,170330,682303,107339,444321,162342,447310,700343,643380,510353,008354,473262,304248,072240,393222,673285,781247,931233,158214,787206,496172,632187,421156,799141,567135,779117,523114,108113,26698,009107,14985,96660,83755,956
       Other Current Assets 
2,153
4,957
3,242
2,970
4,761
7,795
1,265
2,565
1,624
2,766
2,306
412
3,174
5,825
4,865
4,388
3,191
2,620
6,204
5,742
8,833
7,567
9,738
7,941
11,980
9,808
10,527
11,448
15,614
15,058
8,917
10,509
8,338
11,205
15,772
14,025
14,349
23,047
23,401
27,174
29,524
31,290
32,687
33,553
38,166
41,089
36,016
36,010
30,420
33,671
40,941
34,630
26,517
33,101
35,340
32,822
35,264
32,793
45,158
57,781
36,799
58,790
84,398
70,864
84,526
91,661
65,881
80,244
78,138
110,332
92,691
3,584
9,072
11,356
159,841
137,947
117,048
106,667
114,177
111,017
91,412
116,095
137,182
116,980
78,137
78,414
220,618
162,294
76,753
97,747
24,650
24,131
24,147
23,348
23,34824,14724,13124,65097,74776,753162,294220,61878,41478,137116,980137,182116,09591,412111,017114,177106,667117,048137,947159,84111,3569,0723,58492,691110,33278,13880,24465,88191,66184,52670,86484,39858,79036,79957,78145,15832,79335,26432,82235,34033,10126,51734,63040,94133,67130,42036,01036,01641,08938,16633,55332,68731,29029,52427,17423,40123,04714,34914,02515,77211,2058,33810,5098,91715,05815,61411,44810,5279,80811,9807,9419,7387,5678,8335,7426,2042,6203,1914,3884,8655,8253,1744122,3062,7661,6242,5651,2657,7954,7612,9703,2424,9572,153
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,332,200
1,382,675
1,407,858
1,820,408
1,846,432
1,838,644
1,858,849
1,897,919
2,004,009
2,007,349
2,061,590
2,121,559
2,155,472
2,174,347
2,196,834
2,391,832
2,402,309
2,444,302
2,430,977
2,488,409
2,578,758
2,593,459
2,649,353
2,649,3532,593,4592,578,7582,488,4092,430,9772,444,3022,402,3092,391,8322,196,8342,174,3472,155,4722,121,5592,061,5902,007,3492,004,0091,897,9191,858,8491,838,6441,846,4321,820,4081,407,8581,382,6751,332,20000000000000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
169,231
211,039
348,188
365,844
380,386
418,112
408,469
425,227
426,092
444,472
447,059
405,741
408,879
431,546
449,979
449,673
458,027
456,462
462,590
484,260
514,807
542,459
495,481
502,255
517,179
476,818
532,030
494,046
542,318
493,186
542,986
491,346
535,629
496,853
567,188
512,260
565,161
507,539
639,335
542,604
658,984
541,358
663,566
540,324
668,020
556,449
734,191
631,827
773,951
675,293
841,755
774,320
818,802
835,554
871,215
882,330
890,738
901,975
906,386
918,194
926,612
917,210
856,215
843,957
833,956
826,382
817,325
805,040
795,104
792,122
806,555
814,654
817,456
820,193
877,111
880,606
883,697
897,248
1,044,076
1,141,183
1,153,512
1,199,944
1,223,538
1,248,585
1,256,505
1,267,299
1,461,666
1,461,676
1,481,884
1,494,570
1,513,854
1,529,427
1,560,277
1,581,741
1,581,7411,560,2771,529,4271,513,8541,494,5701,481,8841,461,6761,461,6661,267,2991,256,5051,248,5851,223,5381,199,9441,153,5121,141,1831,044,076897,248883,697880,606877,111820,193817,456814,654806,555792,122795,104805,040817,325826,382833,956843,957856,215917,210926,612918,194906,386901,975890,738882,330871,215835,554818,802774,320841,755675,293773,951631,827734,191556,449668,020540,324663,566541,358658,984542,604639,335507,539565,161512,260567,188496,853535,629491,346542,986493,186542,318494,046532,030476,818517,179502,255495,481542,459514,807484,260462,590456,462458,027449,673449,979431,546408,879405,741447,059444,472426,092425,227408,469418,112380,386365,844348,188211,039169,231
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,513
11,513
11,513
11,513
11,513
11,513
11,513
11,513
11,513
11,513
11,513
11,513
11,513
11,513
11,513
11,513
11,513
11,513
11,513
11,513
11,513
11,513
11,513
11,513
11,513
11,513
11,513
11,513
11,513
11,513
11,513
7,920
7,920
7,920
7,920
7,920
7,920
7,920
7,920
7,920
7,920
7,920
7,920
7,9207,9207,9207,9207,9207,9207,9207,9207,9207,9207,9207,92011,51311,51311,51311,51311,51311,51311,51311,51311,51311,51311,51311,51311,51311,51311,51311,51311,51311,51311,51311,51311,51311,51311,51311,51311,51311,51311,51311,51311,51311,51311,513000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
115,405
170,772
220,257
116,692
130,582
124,773
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000124,773130,582116,692220,257170,772115,40500000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
320
9,086
8,399
7,995
15,747
7,120
27,033
26,268
25,857
24,911
24,646
23,687
22,788
22,135
23,051
23,307
33,640
20,648
33,865
18,803
34,197
16,768
33,682
14,703
14,218
53,067
12,952
76,339
11,723
74,864
10,681
76,340
9,408
75,425
8,244
72,934
10,462
97,520
42,979
159,046
42,806
175,659
42,932
175,213
41,731
181,441
39,887
179,853
39,420
183,575
39,143
171,675
173,646
172,605
171,770
171,240
170,322
169,304
170,815
174,444
173,533
172,653
135,046
133,809
132,702
132,401
131,291
130,028
120,716
135,692
134,972
166,621
40,820
165,838
171,315
170,610
177,858
180,213
208,751
210,857
218,825
225,537
225,798
227,769
233,660
235,550
244,866
250,207
275,130
278,896
285,630
286,908
289,742
288,665
288,665289,742286,908285,630278,896275,130250,207244,866235,550233,660227,769225,798225,537218,825210,857208,751180,213177,858170,610171,315165,83840,820166,621134,972135,692120,716130,028131,291132,401132,702133,809135,046172,653173,533174,444170,815169,304170,322171,240171,770172,605173,646171,67539,143183,57539,420179,85339,887181,44141,731175,21342,932175,65942,806159,04642,97997,52010,46272,9348,24475,4259,40876,34010,68174,86411,72376,33912,95253,06714,21814,70333,68216,76834,19718,80333,86520,64833,64023,30723,05122,13522,78823,68724,64624,91125,85726,26827,0337,12015,7477,9958,3999,086320
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
30,160
60,160
86,567
78,256
77,655
74,610
978,858
74,743
82,354
63,239
66,946
70,402
75,288
70,772
74,414
38,942
39,607
35,574
40,282
44,962
41,314
125,087
46,159
46,159125,08741,31444,96240,28235,57439,60738,94274,41470,77275,28870,40266,94663,23982,35474,743978,85874,61077,65578,25686,56760,16030,16000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
102,285
210,230
173,329
161,190
166,397
142,401
123,549
136,900
146,939
142,434
160,930
197,782
203,086
258,993
304,857
331,433
461,762
486,082
493,081
505,661
494,912
529,123
445,103
431,988
511,901
478,108
449,727
527,970
496,551
517,379
511,466
554,086
565,713
533,479
526,776
493,357
447,706
559,421
522,019
540,944
558,661
572,468
552,993
580,365
666,256
677,691
675,474
740,529
783,941
794,837
926,723
1,026,857
1,044,035
1,018,290
1,090,604
1,097,498
1,050,772
1,110,070
1,121,037
1,275,766
1,292,236
1,291,464
1,337,600
1,421,117
1,476,963
1,540,227
1,547,259
1,598,325
1,671,967
1,692,771
1,716,211
1,789,444
1,903,711
2,011,010
2,232,496
2,285,543
2,130,705
2,130,701
2,188,231
2,309,040
2,290,815
2,232,586
2,258,628
2,432,705
2,287,068
2,327,434
2,714,478
2,599,090
2,587,463
2,264,661
2,472,494
2,732,348
2,740,826
2,642,218
2,642,2182,740,8262,732,3482,472,4942,264,6612,587,4632,599,0902,714,4782,327,4342,287,0682,432,7052,258,6282,232,5862,290,8152,309,0402,188,2312,130,7012,130,7052,285,5432,232,4962,011,0101,903,7111,789,4441,716,2111,692,7711,671,9671,598,3251,547,2591,540,2271,476,9631,421,1171,337,6001,291,4641,292,2361,275,7661,121,0371,110,0701,050,7721,097,4981,090,6041,018,2901,044,0351,026,857926,723794,837783,941740,529675,474677,691666,256580,365552,993572,468558,661540,944522,019559,421447,706493,357526,776533,479565,713554,086511,466517,379496,551527,970449,727478,108511,901431,988445,103529,123494,912505,661493,081486,082461,762331,433304,857258,993203,086197,782160,930142,434146,939136,900123,549142,401166,397161,190173,329210,230102,285
   > Total Current Liabilities 
91,100
205,182
173,329
161,190
166,397
142,401
120,049
136,900
146,939
142,434
160,030
196,882
202,186
258,092
303,957
330,533
460,862
485,182
492,181
504,761
494,013
528,223
444,202
431,088
507,767
473,974
446,376
524,620
493,200
514,029
508,115
550,736
562,363
530,128
454,326
420,906
375,255
486,970
479,008
497,934
483,623
497,430
549,663
577,034
663,480
634,914
611,658
676,977
660,690
655,266
655,069
706,369
727,370
747,548
938,649
994,244
945,791
948,035
977,863
1,191,082
1,208,025
1,205,236
1,251,061
1,335,497
1,379,116
1,443,923
1,489,630
1,543,592
1,617,122
1,637,408
1,639,965
1,714,015
1,809,700
1,917,792
2,034,707
2,053,418
1,901,968
1,906,994
2,065,178
2,015,915
1,931,236
1,870,711
1,920,417
2,124,879
2,003,122
2,057,978
2,344,641
2,129,845
2,123,978
1,821,899
2,013,636
2,252,977
2,263,238
2,159,403
2,159,4032,263,2382,252,9772,013,6361,821,8992,123,9782,129,8452,344,6412,057,9782,003,1222,124,8791,920,4171,870,7111,931,2362,015,9152,065,1781,906,9941,901,9682,053,4182,034,7071,917,7921,809,7001,714,0151,639,9651,637,4081,617,1221,543,5921,489,6301,443,9231,379,1161,335,4971,251,0611,205,2361,208,0251,191,082977,863948,035945,791994,244938,649747,548727,370706,369655,069655,266660,690676,977611,658634,914663,480577,034549,663497,430483,623497,934479,008486,970375,255420,906454,326530,128562,363550,736508,115514,029493,200524,620446,376473,974507,767431,088444,202528,223494,013504,761492,181485,182460,862330,533303,957258,092202,186196,882160,030142,434146,939136,900120,049142,401166,397161,190173,329205,18291,100
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
42,000
1,144
1,180
348,000
448,000
514,000
490,759
508,514
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000508,514490,759514,000448,000348,0001,1801,14442,00000000000000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
42,000
1,144
1,180
348,000
448,000
514,000
490,759
508,514
543,339
536,057
462,419
358,498
355,014
274,697
425,418
466,245
436,220
408,725
410,906
405,741
455,762
390,719
344,286
433,732
389,609
383,143
383,143389,609433,732344,286390,719455,762405,741410,906408,725436,220466,245425,418274,697355,014358,498462,419536,057543,339508,514490,759514,000448,000348,0001,1801,14442,00000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
16,929
24,080
26,418
26,300
31,093
28,278
27,583
26,412
34,307
39,981
32,269
23,993
28,715
46,438
64,142
84,311
74,949
90,694
97,206
90,158
96,840
106,159
100,542
98,101
147,388
152,004
145,368
210,044
235,266
234,396
221,163
260,912
281,993
205,924
149,391
167,483
165,233
158,958
148,167
159,071
162,901
165,765
163,630
182,341
189,364
196,072
176,603
225,697
220,040
216,747
203,935
278,081
294,508
278,696
280,344
278,135
266,591
302,073
282,728
379,182
398,730
373,756
439,366
579,519
623,279
583,837
557,385
561,319
681,368
788,898
781,545
870,086
823,564
889,993
962,268
933,631
767,352
735,758
712,291
744,388
701,646
678,114
612,934
748,433
670,060
696,828
722,742
734,189
771,728
551,351
746,107
871,584
888,994
776,153
776,153888,994871,584746,107551,351771,728734,189722,742696,828670,060748,433612,934678,114701,646744,388712,291735,758767,352933,631962,268889,993823,564870,086781,545788,898681,368561,319557,385583,837623,279579,519439,366373,756398,730379,182282,728302,073266,591278,135280,344278,696294,508278,081203,935216,747220,040225,697176,603196,072189,364182,341163,630165,765162,901159,071148,167158,958165,233167,483149,391205,924281,993260,912221,163234,396235,266210,044145,368152,004147,38898,101100,542106,15996,84090,15897,20690,69474,94984,31164,14246,43828,71523,99332,26939,98134,30726,41227,58328,27831,09326,30026,41824,08016,929
       Other Current Liabilities 
30,191
64,122
76,931
76,894
74,204
69,623
52,466
45,488
47,632
37,453
52,761
62,389
52,971
83,154
68,315
58,222
57,913
86,488
86,975
96,603
87,373
132,264
89,980
94,307
90,579
107,170
126,208
107,876
74,434
81,133
68,452
67,124
69,270
67,804
93,535
83,423
67,022
101,612
99,441
107,463
89,022
93,465
127,833
126,493
149,116
154,342
155,555
157,080
158,050
169,119
175,628
177,681
180,256
174,345
195,071
180,076
166,920
187,081
202,136
225,500
267,294
242,481
281,695
270,977
275,837
331,386
423,545
486,367
454,080
463,828
259,668
1,180
1,216
961
289,184
560,872
523,377
584,829
406,737
735,895
678,770
732,279
745,281
797,817
729,840
794,750
955,446
826,067
318,136
750,695
10,193
8,181
6,332
6,822
6,8226,3328,18110,193750,695318,136826,067955,446794,750729,840797,817745,281732,279678,770735,895406,737584,829523,377560,872289,1849611,2161,180259,668463,828454,080486,367423,545331,386275,837270,977281,695242,481267,294225,500202,136187,081166,920180,076195,071174,345180,256177,681175,628169,119158,050157,080155,555154,342149,116126,493127,83393,46589,022107,46399,441101,61267,02283,42393,53567,80469,27067,12468,45281,13374,434107,876126,208107,17090,57994,30789,980132,26487,37396,60386,97586,48857,91358,22268,31583,15452,97162,38952,76137,45347,63245,48852,46669,62374,20476,89476,93164,12230,191
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
75,429
94,011
93,218
197,790
232,125
228,737
223,707
123,053
293,126
359,580
361,875
338,211
307,826
283,946
269,456
369,837
469,245
463,484
442,763
458,858
479,371
477,589
482,814
482,814477,589479,371458,858442,763463,484469,245369,837269,456283,946307,826338,211361,875359,580293,126123,053223,707228,737232,125197,79093,21894,01175,42900000000000000000000000000000000000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-42,000
-1,144
-1,180
-348,000
-448,000
-514,000
-490,759
-508,514
0
0
0
58,371
59,189
54,256
28,042
26,222
26,735
24,234
20,711
17,782
17,226
16,956
20,214
20,153
16,361
15,119
15,11916,36120,15320,21416,95617,22617,78220,71124,23426,73526,22228,04254,25659,18958,371000-508,514-490,759-514,000-448,000-348,000-1,180-1,144-42,00000000000000000000000000000000000000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
105,119
140,194
138,692
0
0
54,956
0
49,942
0
49,928
0
0
0
0
0
0
0
0
0
0
000000000049,928049,942054,95600138,692140,194105,11900000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
40,091
43,970
45,946
50,620
50,634
45,696
68,804
67,516
71,953
74,787
80,807
84,941
89,796
97,437
94,656
99,409
105,608
109,648
106,320
118,310
121,618
125,886
0
0
0
0
0000125,886121,618118,310106,320109,648105,60899,40994,65697,43789,79684,94180,80774,78771,95367,51668,80445,69650,63450,62045,94643,97040,09100000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
531,422
528,530
535,072
538,703
544,003
555,427
560,874
564,657
569,434
574,481
575,995
579,326
583,448
588,338
585,586
588,237
591,211
594,479
594,612
596,982
600,334
601,540
615,377
625,240
634,770
628,013
633,421
635,221
638,838
643,316
647,604
650,336
655,886
667,779
671,491
676,388
693,166
707,201
713,541
718,499
726,700
728,898
723,455
726,080
726,270
731,754
734,159
1,020,211
998,128
1,008,810
1,013,604
1,010,856
1,025,563
1,104,193
1,112,442
1,118,774
1,144,343
1,145,683
1,150,679
1,137,468
1,121,898
1,152,241
1,152,774
1,156,607
1,195,213
1,204,940
1,220,456
1,218,468
1,247,884
1,272,225
1,288,676
1,302,192
1,304,954
1,318,593
1,324,319
1,344,646
1,373,147
1,383,944
1,413,489
1,441,663
1,476,949
1,503,707
1,528,153
1,561,451
1,583,664
1,713,425
1,728,488
1,782,818
1,819,443
1,865,167
1,889,410
1,939,900
1,948,735
1,996,909
1,996,9091,948,7351,939,9001,889,4101,865,1671,819,4431,782,8181,728,4881,713,4251,583,6641,561,4511,528,1531,503,7071,476,9491,441,6631,413,4891,383,9441,373,1471,344,6461,324,3191,318,5931,304,9541,302,1921,288,6761,272,2251,247,8841,218,4681,220,4561,204,9401,195,2131,156,6071,152,7741,152,2411,121,8981,137,4681,150,6791,145,6831,144,3431,118,7741,112,4421,104,1931,025,5631,010,8561,013,6041,008,810998,1281,020,211734,159731,754726,270726,080723,455728,898726,700718,499713,541707,201693,166676,388671,491667,779655,886650,336647,604643,316638,838635,221633,421628,013634,770625,240615,377601,540600,334596,982594,612594,479591,211588,237585,586588,338583,448579,326575,995574,481569,434564,657560,874555,427544,003538,703535,072528,530531,422
   Common Stock
65,002
65,002
65,002
65,002
65,002
65,002
65,002
65,002
65,002
65,002
130,005
130,005
130,005
130,005
130,005
130,005
260,009
260,009
260,009
260,009
260,009
260,009
260,009
260,009
260,009
260,009
260,009
260,009
260,009
260,009
260,009
260,009
260,009
260,009
260,009
260,009
260,009
260,009
260,009
260,009
260,009
260,009
260,009
260,009
260,009
260,009
260,009
312,141
312,141
312,141
312,141
312,141
312,141
312,141
312,141
312,141
312,141
312,141
312,141
312,141
312,141
312,141
312,141
312,141
312,141
312,141
317,078
317,078
317,078
317,078
317,078
312,141
312,141
312,141
312,141
312,141
312,141
312,141
312,141
312,141
312,141
312,141
312,141
312,141
312,141
332,111
332,111
332,111
332,111
332,111
0
0
0
0
0000332,111332,111332,111332,111332,111312,141312,141312,141312,141312,141312,141312,141312,141312,141312,141312,141312,141312,141312,141317,078317,078317,078317,078317,078312,141312,141312,141312,141312,141312,141312,141312,141312,141312,141312,141312,141312,141312,141312,141312,141312,141312,141312,141260,009260,009260,009260,009260,009260,009260,009260,009260,009260,009260,009260,009260,009260,009260,009260,009260,009260,009260,009260,009260,009260,009260,009260,009260,009260,009260,009260,009260,009260,009260,009130,005130,005130,005130,005130,005130,00565,00265,00265,00265,00265,00265,00265,00265,00265,00265,002
   Retained Earnings 
29,782
27,523
33,097
36,728
42,125
53,550
53,799
57,582
57,826
62,872
52,951
56,282
60,404
65,294
61,103
63,754
66,728
69,995
68,775
71,145
74,497
76,823
88,579
98,443
111,783
105,026
104,909
106,710
110,326
114,805
118,571
121,303
126,852
138,746
140,696
145,593
162,371
176,406
179,481
184,439
192,640
194,838
188,593
191,219
172,577
178,061
180,466
183,197
161,122
171,804
176,598
207,673
222,381
239,452
244,631
250,612
263,277
276,955
277,020
271,183
259,772
276,536
273,743
283,112
317,293
334,085
339,091
350,532
377,172
395,526
400,017
386,792
395,598
414,173
449,974
471,364
507,725
520,620
553,694
580,979
617,276
643,907
668,291
704,046
725,577
763,575
805,138
851,163
874,943
914,391
888,735
935,746
939,144
986,234
986,234939,144935,746888,735914,391874,943851,163805,138763,575725,577704,046668,291643,907617,276580,979553,694520,620507,725471,364449,974414,173395,598386,792400,017395,526377,172350,532339,091334,085317,293283,112273,743276,536259,772271,183277,020276,955263,277250,612244,631239,452222,381207,673176,598171,804161,122183,197180,466178,061172,577191,219188,593194,838192,640184,439179,481176,406162,371145,593140,696138,746126,852121,303118,571114,805110,326106,710104,909105,026111,78398,44388,57976,82374,49771,14568,77569,99566,72863,75461,10365,29460,40456,28252,95162,87257,82657,58253,79953,55042,12536,72833,09727,52329,782
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000-31,247-31,247-31,247-31,247000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
76,844
81,406
80,969
77,938
71,895
66,957
66,655
65,592
57,732
55,634
52,106
52,994
51,983
52,111
52,172
49,715
50,397
55,724
55,184
54,049
57,452
54,287
0
0
0
0
000054,28757,45254,04955,18455,72450,39749,71552,17252,11151,98352,99452,10655,63457,73265,59266,65566,95771,89577,93880,96981,40676,84400000000000000000000000000000000000000000000000000000000000000000000



6.3. Balance Sheets

Currency in CNY. All numbers in thousands.




6.4. Cash Flows

Currency in CNY. All numbers in thousands.




6.5. Income Statements

Currency in CNY. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in CNY. All numbers in thousands.

Gross Profit (+$)
totalRevenue4,275,437
Cost of Revenue-3,176,289
Gross Profit1,099,1481,099,148
 
Operating Income (+$)
Gross Profit1,099,148
Operating Expense-4,033,356
Operating Income242,081-2,934,209
 
Operating Expense (+$)
Research Development77,023
Selling General Administrative618,265
Selling And Marketing Expenses0
Operating Expense4,033,356695,289
 
Net Interest Income (+$)
Interest Income8,711
Interest Expense-33,894
Other Finance Cost-747
Net Interest Income-25,931
 
Pretax Income (+$)
Operating Income242,081
Net Interest Income-25,931
Other Non-Operating Income Expenses0
Income Before Tax (EBT)214,893242,081
EBIT - interestExpense = -33,894
159,286
193,180
Interest Expense33,894
Earnings Before Interest and Taxes (EBIT)0248,787
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax214,893
Tax Provision-57,596
Net Income From Continuing Ops157,297157,297
Net Income159,286
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net025,931
 

Technical Analysis of Anhui Fengyuan Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Anhui Fengyuan Pharmaceutical Co Ltd. The general trend of Anhui Fengyuan Pharmaceutical Co Ltd is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Anhui Fengyuan Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Anhui Fengyuan Pharmaceutical Co Ltd Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Anhui Fengyuan Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 6.9004919095379 < 6.96 < 6.97.

The bearish price targets are: 6.24 > 6.24 > 5.93.

Know someone who trades $000153? Share this with them.👇

Anhui Fengyuan Pharmaceutical Co Ltd Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Anhui Fengyuan Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Anhui Fengyuan Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Anhui Fengyuan Pharmaceutical Co Ltd. The current macd is 0.03602968.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Anhui Fengyuan Pharmaceutical Co Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Anhui Fengyuan Pharmaceutical Co Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Anhui Fengyuan Pharmaceutical Co Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Anhui Fengyuan Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartAnhui Fengyuan Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Anhui Fengyuan Pharmaceutical Co Ltd. The current adx is 12.09.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Anhui Fengyuan Pharmaceutical Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Anhui Fengyuan Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Anhui Fengyuan Pharmaceutical Co Ltd. The current sar is 5.99.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Anhui Fengyuan Pharmaceutical Co Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Anhui Fengyuan Pharmaceutical Co Ltd. The current rsi is 61.35. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Anhui Fengyuan Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartAnhui Fengyuan Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Anhui Fengyuan Pharmaceutical Co Ltd. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Anhui Fengyuan Pharmaceutical Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Anhui Fengyuan Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartAnhui Fengyuan Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Anhui Fengyuan Pharmaceutical Co Ltd. The current cci is 124.64.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Anhui Fengyuan Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartAnhui Fengyuan Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Anhui Fengyuan Pharmaceutical Co Ltd. The current cmo is 33.16.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Anhui Fengyuan Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartAnhui Fengyuan Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Anhui Fengyuan Pharmaceutical Co Ltd. The current willr is -5.12820513.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Anhui Fengyuan Pharmaceutical Co Ltd Daily Williams %R ChartAnhui Fengyuan Pharmaceutical Co Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Anhui Fengyuan Pharmaceutical Co Ltd.

Anhui Fengyuan Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Anhui Fengyuan Pharmaceutical Co Ltd. The current atr is 0.12799845.

Anhui Fengyuan Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartAnhui Fengyuan Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Anhui Fengyuan Pharmaceutical Co Ltd. The current obv is 552,605,140.

Anhui Fengyuan Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartAnhui Fengyuan Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Anhui Fengyuan Pharmaceutical Co Ltd. The current mfi is 70.54.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Anhui Fengyuan Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartAnhui Fengyuan Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Anhui Fengyuan Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-10-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-11-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-11-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-11-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-12-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-25BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-02MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-01-06STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-01-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-02-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-02-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-02-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-17STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-24STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-03-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.

6.3. Candlestick Patterns

Anhui Fengyuan Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Anhui Fengyuan Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.354
Ma 20Greater thanMa 506.120
Ma 50Greater thanMa 1006.072
Ma 100Greater thanMa 2006.251
OpenGreater thanClose6.270
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Anhui Fengyuan Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Anhui Fengyuan Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Anhui Fengyuan Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Anhui Fengyuan Pharmaceutical Co Ltd

I send you an email if I find something interesting about Anhui Fengyuan Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Anhui Fengyuan Pharmaceutical Co Ltd.

Receive notifications about Anhui Fengyuan Pharmaceutical Co Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.